HRX Innovation Challenge: Deadline is June 3, 2024

HRX Innovation Challenge: Deadline is June 3, 2024

Renée Arnold


BioHealth Innovation, Inc. & the NIH/NHLBI

Speaker Sessions

September 05, 2024 | 02:15 PM (EDT) - 03:00 PM (EDT)

About Renée JG Arnold, PharmD

Renée JG Arnold is currently Entrepreneur-in-Residence with both BioHealth Innovation, Inc. and the NIH/NHLBI, with expertise in Health Economics and Outcomes Research (HEOR) and evidence development related to reimbursement. She is also President & CEO, Arnold Consultancy & Technology, LLC, where she oversees outcomes research and develops affiliated software for pharmaceutical and government programs. Her special interest in evidence-based health derives from her research that deals with use of technology to collect and/or model real-world data for use in rational decision-making by healthcare practitioners and policy makers. In addition, Dr. Arnold is Adjunct Professor, Master of Public Health program, Department of Environmental Medicine and Climate Science at the Icahn School of Medicine at Mount Sinai, New York, New York, where she has developed and teaches the pharmacoeconomics coursework.

Dr. Arnold completed her undergraduate training at the University of Maryland and received her Doctor of Pharmacy degree from the University of Southern California in Los Angeles. She also completed a post-doctoral residency at University Hospital in San Diego/University of California at San Francisco School of Pharmacy. Dr. Arnold is a founding member of ISPOR, the 20,000-member leading professional society for HEOR globally, and is the Chair of multiple special interest groups (SIGS) there including, most recently, the Open Source Model SIG. Dr. Arnold is an author of numerous articles, book chapters and books in the areas of pharmacology, pharmacoeconomics and cost containment strategies and the 2nd edition of her pharmacoeconomics textbook ( .